Effect of chitooligosaccharides on cyclin D1,bcl-xl and bcl-2 mRNA expression in A549 cells using quantitative PCR

被引:0
|
作者
LI Xian 1
2 Bioengineering Institute
机构
基金
国家高技术研究发展计划(863计划);
关键词
chitooligosaccharides; cyclin D1; bcl-xl; bcl-2;
D O I
暂无
中图分类号
Q55 [酶];
学科分类号
071010 ; 081704 ;
摘要
Chitooligosaccharide (COS) is derived from the chemical and enzymatic hydrolysis of chitosan and has been reported to have potent antitumor activity.Our study investigated the effects of five chitooligomers ranging from the dimer form to the hexamer form (chitobiose,chitotriose,chitotetraose,chitopentaose,chitohexaose) on the expression of cyclin D1,bcl-2 and bcl-xl mRNA in A549 cells using reverse transcription quantitative real-time PCR.We demonstrated that,of the five chitooligomers used,chitohexaose (COS6) had the most potent inhibitory effect on A549 cell proliferation.COS6 also significantly down regulated cyclin D1 and bcl-xl mRNA expression levels.Our data suggested that COS6 exerts its antitumor activity by two different mechanisms:(1) COS6-mediated inhibition of Cyclin D1 levels leads to suppression of tumor cell proliferation;and (2) COS6-mediated down-regulation of the pro-survival protein,Bcl-xl,promotes the apoptosis of tumor cells.
引用
收藏
页码:1629 / 1632
页数:4
相关论文
共 50 条
  • [41] Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins
    Zhuang, Liqing
    Scolyer, Richard A.
    Murali, Rajmohan
    McCarthy, Stanley W.
    Zhang, Xu Dong
    Thompson, John F.
    Hersey, Peter
    MODERN PATHOLOGY, 2010, 23 (01) : 45 - 53
  • [42] MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-XL, and Mcl-1 and promotes survival of human pancreatic cancer cells
    Boucher, MJ
    Morisset, J
    Vachon, PH
    Reed, JC
    Lainé, J
    Rivard, N
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2000, 79 (03) : 355 - 369
  • [43] Increase of the therapeutic effect on non-small-cell lung cancer cells with combination treatment of shRNA against Cyclin D1 and Bcl-xL in vitro
    Chen, Ying
    Cao, Yong
    Yang, Danlei
    Li, Kaiyan
    Wang, Zhengyun
    Zhu, Jing
    Bunjhoo, Hansvin
    Xiong, Shengdao
    Xu, Yongjian
    Xiong, Weining
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 3 (02) : 255 - 260
  • [44] Cannabinoids Regulate Bcl-2 and Cyclin D2 Expression in Pancreatic β Cells
    Kim, Jihye
    Lee, Kyung Jin
    Kim, Jung Seok
    Rho, Jun Gi
    Shin, Jung Jae
    Song, Woo Keun
    Lee, Eun Kyung
    Egan, Josephine M.
    Kim, Wook
    PLOS ONE, 2016, 11 (03):
  • [45] Cyclin-Dependent Kinase 1-Mediated Bcl-xL/Bcl-2 Phosphorylation Acts as a Functional Link Coupling Mitotic Arrest and Apoptosis
    Terrano, David T.
    Upreti, Meenakshi
    Chambers, Timothy C.
    MOLECULAR AND CELLULAR BIOLOGY, 2010, 30 (03) : 640 - 656
  • [46] Cell cycle arrest mediated by a pyridopyrimidine is not abrogated by over-expression of Bcl-2 and cyclin D1
    Soni, R
    Chaudhuri, B
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 18 (05) : 1035 - 1040
  • [47] Chemosensitization of carcinoma cells using epithelial cell adhesion molecule-targeted liposomal antisense against bcl-2/bcl-xL
    Hussain, Sajid
    Plueckthun, Andreas
    Allen, Theresa M.
    Zangemeister-Wittke, Uwe
    MOLECULAR CANCER THERAPEUTICS, 2006, 5 (12) : 3170 - 3180
  • [48] Distribution of Bim determines Mcl-1 dependence or codependence with Bcl-xL/Bcl-2 in Mcl-1-expressing myeloma cells
    Morales, Alejo A.
    Kurtoglu, Metin
    Matulis, Shannon M.
    Liu, Jiangxia
    Siefker, David
    Gutman, Delia M.
    Kaufman, Jonathan L.
    Lee, Kelvin P.
    Lonial, Sagar
    Boise, Lawrence H.
    BLOOD, 2011, 118 (05) : 1329 - 1339
  • [49] Ginsenoside Rh2 induces apoptosis independently of Bcl-2, Bcl-xL or Bax in C6Bu-1 cells
    Young Sook Kim
    Sung Ha Jin
    You Hui Lee
    Shin Kim
    Jong Dae Park
    Archives of Pharmacal Research, 1999, 22 : 448 - 453
  • [50] Ginsenoside Rh2 induces apoptosis independently of Bcl-2, Bcl-xL or Bax in C6Bu-1 cells
    Kim, YS
    Jin, SH
    Lee, YH
    Kim, SI
    Park, JD
    ARCHIVES OF PHARMACAL RESEARCH, 1999, 22 (05) : 448 - 453